| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |